DHL Express will expand its existing Medical Express service between Mexico and the United States, the Florida-based company announced Tuesday.
The service, which DHL launched in Mexico in July 2018, facilitates the delivery of Mexico-based patient samples to U.S. central labs in fewer than 24 hours.
This reduces transit times for urgent temperature-sensitive shipments from primary cities by an additional day.
DHL exports from multiple gateways in Mexico, operating direct daily flights from Mexico City, Guadalajara and Monterey, linking to its regional hub at Cincinnati/Northern Kentucky International Airport, and then connecting to most U.S. cities and central lab locations the next morning and in less than 24 hours from patient draw time.
The service will expand by April into 17 new cities, including Zapopan, Toluca, Cuernavaca, Cuatla, Pachuca, Saltillo, Aguascalientes, Puebla, Celaya, San Luis Potosi, Torreon, Morelia, Leon, Guanajuato, Jalapa, Orizaba and Durango.
“Sponsor pharmaceutical companies have told us that the enhanced transit times have delivered significant improvements during prospective sample analysis, and improved testing results — particularly for Biomarkers and Flow Cytometry Assays,” said Brian Bralynski of DHL Express Americas. “Those types of gains are highly impactful and a direct benefit to patients requiring such treatment or sample analysis.”
The service is suitable for transporting laboratory kits and medical devices, biological samples, research products, vaccines and drugs for commercial and non-commercial use. Shipments have three temperature options: ambient, chilled and frozen.
DHL is the first such integrator in Mexico and South America geared toward the needs of the clinical research sector.